China Boton Group Signs Contract with Influential E-Cigarette Company

Sep.02.2024

China Boton Group signs a contract with a significant Chinese e-cigarette company, promising sales totaling 19 billion RMB in 36 months.

Recently, the board of directors of China Boton Group Limited released a latest announcement, stating that they have successfully signed a contract with a Chinese e-cigarette company on August 29th. According to the contract, China Boton Group will supply e-cigarette and e-liquid products for a period of 36 months, with a total sales volume of not less than 1.9 billion yuan (approximately 2.1 billion Hong Kong dollars).

It is reported that China Boton Group has not disclosed its partner, but mentioned that the e-cigarette company they are collaborating with is "highly influential.

China Boton Group has obtained the necessary production licenses for the e-cigarette supply chain. The company claims to have the capability to supply custom e-cigarette and e-liquid products, and can design and produce different styles of e-cigarettes to promote the development of the company's e-cigarette products department.

References:

[1] 中國波頓自願性公告最新業務發展

Also Read:

[1] China Boton (3318.HK) Mid-Year Report: Revenue Down 6.7% to 750M Yuan, E-Cig Business Decreases by 21% YoY

[2] 103% Surge in 10 Days: What Does China Boton 2023 Performance Report Reveal?

[3] China Boton's E-cigarette Revenue Declines Due to New Policies

[4] China Boton Announces Sale of Subsidiary Mons

#E-liquids #Asia #China #Major companies

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NZ Government Eyes Sale of Smokeless Tobacco; Critics Warn of “Backslide”

Associate Health Minister Casey Costello faced renewed scrutiny in Parliament’s health select committee over her handling of tobacco-related policy and alleged ties to the tobacco industry. The government is considering allowing smokeless nicotine products such as snus and nicotine pouches, provided they meet safety and youth-access regulations.

Dec.05 by 2FIRSTS.ai

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

Mexico’s Congress Prepares Total Ban on Vapes and E-Cigarettes

Mexico’s Chamber of Deputies is preparing to vote on several major bills before the end of the legislative session, including a full ban on vapes and e-cigarettes. The proposed reform to the General Health Law would prohibit the manufacturing, sale, import, and export of these products, imposing penalties of up to eight years in prison and fines exceeding 200,000 pesos (approximately USD 11,000). L

Dec.09 by 2FIRSTS.ai

PMI Q3 2025 Earnings: Net Revenues Reach $10.85 Billion, Smoke-Free Products Account for 41% of Sales

PMI reported strong third-quarter 2025 results, underscoring the continued success of its smoke-free transformation. Net revenues rose 9.4% year-over-year to $10.85 billion, driven by robust growth in the smoke-free segment, which now accounts for 41% of total net revenues and over 42% of gross profit.Despite a 3.2% decline in cigarette shipments, combustible revenues climbed 4.3% thanks to strong pricing.